Two patients, one with HER2-positive and one with HER2-ngative tumor, had an asymptomatic ≤10% left ventricular ejection fraction (LVEF) reduction from baseline with a final value, at treatment completion, of 50%. Here, ERBB2 is linked to neoplasm.